Download PDF
Horm Metab Res 1989; 21(8): 438-440
DOI: 10.1055/s-2007-1009256
Clinical

© Georg Thieme Verlag, Stuttgart · New York

Urinary N-Acetyl-β-D-Glucosaminidase in the Patients with Hyperthyroidism

M. Tominaga, K. Fujiyama, T. Hoshino, Y. Tanaka, T. Takeuchi, M. Honda, O. Mokuda, T. Ikeda, H. Mashiba
  • The First Department of Internal Medicine, Tottori University School of Medicine, Yonago, Japan
Further Information

Publication History

1988

1988

Publication Date:
14 March 2008 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

Urinary N-acetyl-β-D-glucosaminidase (NAG) was measured in patients with hyperthyroidism. The value of urinary NAG in these patients was higher than that in normal subjects and diabetic patients without diabetic nephropathy. This high level of urinary NAG in patients with hyperthyroidism decreased to the level of normal subjects after treatment of hyperthyroidism.

Why urinary NAG increases in the patients with hyperthyroidism remains unknown. On the occasion of estimating the significance of the high level of urinary NAG, however, the possibility of the existence of hyperthyroidism has to be considered in addition to renal damage or hyperglycemia which have already been found to increase urinary NAG.

Key words

Urinary N-Acetyl-β-D-Glucosaminise - Hyperthyroidism

      >